Omnipod: Device intended for the subcutaneous delivery of insulin into a patient — FDA announcement May 26, 2026

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date May 26, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Device intended for the subcutaneous delivery of insulin into a patient
Reason
Manufacturing issue that could result in under delivery of insulin
Classification
Not supplied
Recalling firm
Insulet Corporation, Inc.
Quantity
Not supplied
Agency-reported status
Company recall announcement
Source record identifier
d93b8f9dd2907b76

Open the official record

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityCustomers should visit Check Pod Lot to confirm whether their Pod lot number is included in this voluntary Medical Device Correction and request replacement Pods at no cost. A full list of affected lots is available on this site.; If a Pod from an affected lot is currently in use, customers should discontinue use and replace it with a Pod from an unaffected lot.

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Fda listing date
May 26, 2026
Company announcement date
May 26, 2026

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records